Grifols presents XEMBIFY (immune globulin subcutaneous human-klhw), a 20% subcutaneous immunoglobulin (IG) for the treatment of primary immunodeficiency diseases. With maximum immunoglobulin G (IgG) potency and purity due to the unique caprylate/chromatography process, XEMBIFY provides a customizable IG treatment option (from weekly to daily) to offer protection from infections.

Grifols